Terlipressina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Terlipressina" in Italian language version.

refsWebsite

Global rank Italian rank

17nih.gov

4^th place

9^th place

9oadoi.org

799^th place

22^nd place

9doi.org

2^nd place

7^th place

doi.org

dx.doi.org

FH. Saner, A. Canbay; G. Gerken; CE. Broelsch, Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome., in Expert Rev Gastroenterol Hepatol, vol. 1, n. 2, Dec 2007, pp. 207-17, DOI:10.1586/17474124.1.2.207, PMID 19072411.
A. Krag, T. Borup; S. Møller; F. Bendtsen, Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome., in Adv Ther, vol. 25, n. 11, Nov 2008, pp. 1105-40, DOI:10.1007/s12325-008-0118-7, PMID 19018483.
S. Walker, [Treatment of esophageal varices bleeding with vasoactive substances]., in Dtsch Med Wochenschr, vol. 113, n. 1, Jan 1988, pp. 26-31, DOI:10.1055/s-2008-1067589, PMID 2891495.
A. Morelli, C. Ertmer; P. Pietropaoli; M. Westphal, Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock., in Expert Opin Pharmacother, vol. 10, n. 15, Oct 2009, pp. 2569-75, DOI:10.1517/14656560903257808, PMID 19735216.
AB. Pesaturo, HR. Jennings; SA. Voils, Terlipressin: vasopressin analog and novel drug for septic shock., in Ann Pharmacother, vol. 40, n. 12, Dec 2006, pp. 2170-7, DOI:10.1345/aph.1H373, PMID 17148649.
A. Delmas, M. Leone; S. Rousseau; J. Albanèse; C. Martin, Clinical review: Vasopressin and terlipressin in septic shock patients., in Crit Care, vol. 9, n. 2, Apr 2005, pp. 212-22, DOI:10.1186/cc2945, PMID 15774080.
LL. Gluud, K. Christensen; E. Christensen; A. Krag, Terlipressin for hepatorenal syndrome., in Cochrane Database Syst Rev, vol. 9, 2012, pp. CD005162, DOI:10.1002/14651858.CD005162.pub3, PMID 22972083.
SV. Sagi, S. Mittal; KS. Kasturi; GK. Sood, Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials., in J Gastroenterol Hepatol, vol. 25, n. 5, maggio 2010, pp. 880-5, DOI:10.1111/j.1440-1746.2009.06132.x, PMID 20074149.
F. Donnellan, G. Cullen; JE. Hegarty; PA. McCormick, Ischaemic complications of Glypressin in liver disease: a case series., in Br J Clin Pharmacol, vol. 64, n. 4, Oct 2007, pp. 550-2, DOI:10.1111/j.1365-2125.2007.02921.x, PMID 17880357.

nih.gov

ncbi.nlm.nih.gov

ML. Forsling, LA. Aziz; M. Miller; R. Davies; B. Donovan, Conversion of triglycylvasopressin to lysine-vasopressin in man., in J Endocrinol, vol. 85, n. 2, maggio 1980, pp. 237-44, PMID 7400711.
FH. Saner, A. Canbay; G. Gerken; CE. Broelsch, Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome., in Expert Rev Gastroenterol Hepatol, vol. 1, n. 2, Dec 2007, pp. 207-17, DOI:10.1586/17474124.1.2.207, PMID 19072411.
A. Krag, T. Borup; S. Møller; F. Bendtsen, Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome., in Adv Ther, vol. 25, n. 11, Nov 2008, pp. 1105-40, DOI:10.1007/s12325-008-0118-7, PMID 19018483.
G. Nilsson, P. Lindblom; M. Ohlin; R. Berling; E. Vernersson, Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers., in Drugs Exp Clin Res, vol. 16, n. 6, 1990, pp. 307-14, PMID 2086166.
JG. Freeman, I. Cobden; AH. Lishman; CO. Record, Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices., in Lancet, vol. 2, n. 8289, Jul 1982, pp. 66-8, PMID 6123808.
C. Söderlund, Vasopressin and glypressin in upper gastrointestinal bleeding., in Scand J Gastroenterol Suppl, vol. 137, 1987, pp. 50-5, PMID 2892263.
S. Walker, [Treatment of esophageal varices bleeding with vasoactive substances]., in Dtsch Med Wochenschr, vol. 113, n. 1, Jan 1988, pp. 26-31, DOI:10.1055/s-2008-1067589, PMID 2891495.
A. Plessier, [Acute upper gastrointestinal variceal bleeding: vasoactive agents]., in Gastroenterol Clin Biol, 28 Spec No 2, Apr 2004, pp. B15-20, PMID 15150493.
A. Morelli, C. Ertmer; P. Pietropaoli; M. Westphal, Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock., in Expert Opin Pharmacother, vol. 10, n. 15, Oct 2009, pp. 2569-75, DOI:10.1517/14656560903257808, PMID 19735216.
AB. Pesaturo, HR. Jennings; SA. Voils, Terlipressin: vasopressin analog and novel drug for septic shock., in Ann Pharmacother, vol. 40, n. 12, Dec 2006, pp. 2170-7, DOI:10.1345/aph.1H373, PMID 17148649.
A. Delmas, M. Leone; S. Rousseau; J. Albanèse; C. Martin, Clinical review: Vasopressin and terlipressin in septic shock patients., in Crit Care, vol. 9, n. 2, Apr 2005, pp. 212-22, DOI:10.1186/cc2945, PMID 15774080.
LL. Gluud, K. Christensen; E. Christensen; A. Krag, Terlipressin for hepatorenal syndrome., in Cochrane Database Syst Rev, vol. 9, 2012, pp. CD005162, DOI:10.1002/14651858.CD005162.pub3, PMID 22972083.
F. Fabrizi, V. Dixit; P. Messa; P. Martin, Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials., in Int J Artif Organs, vol. 32, n. 3, Mar 2009, pp. 133-40, PMID 19440988.
SV. Sagi, S. Mittal; KS. Kasturi; GK. Sood, Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials., in J Gastroenterol Hepatol, vol. 25, n. 5, maggio 2010, pp. 880-5, DOI:10.1111/j.1440-1746.2009.06132.x, PMID 20074149.
E. Yefet, M. Gershovich; E. Farber; S. Soboh, Extensive epidermal necrosis due to terlipressin., in Isr Med Assoc J, vol. 13, n. 3, Mar 2011, pp. 180-1, PMID 21608341.
JE. Oh, JS. Ha; DH. Cho; GJ. Yu; SG. Shim, [A case of ischemic skin necrosis after glypressin therapy in liver cirrhosis]., in Korean J Gastroenterol, vol. 51, n. 6, Jun 2008, pp. 381-4, PMID 18604141.
F. Donnellan, G. Cullen; JE. Hegarty; PA. McCormick, Ischaemic complications of Glypressin in liver disease: a case series., in Br J Clin Pharmacol, vol. 64, n. 4, Oct 2007, pp. 550-2, DOI:10.1111/j.1365-2125.2007.02921.x, PMID 17880357.

oadoi.org

FH. Saner, A. Canbay; G. Gerken; CE. Broelsch, Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome., in Expert Rev Gastroenterol Hepatol, vol. 1, n. 2, Dec 2007, pp. 207-17, DOI:10.1586/17474124.1.2.207, PMID 19072411.
A. Krag, T. Borup; S. Møller; F. Bendtsen, Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome., in Adv Ther, vol. 25, n. 11, Nov 2008, pp. 1105-40, DOI:10.1007/s12325-008-0118-7, PMID 19018483.
S. Walker, [Treatment of esophageal varices bleeding with vasoactive substances]., in Dtsch Med Wochenschr, vol. 113, n. 1, Jan 1988, pp. 26-31, DOI:10.1055/s-2008-1067589, PMID 2891495.
A. Morelli, C. Ertmer; P. Pietropaoli; M. Westphal, Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock., in Expert Opin Pharmacother, vol. 10, n. 15, Oct 2009, pp. 2569-75, DOI:10.1517/14656560903257808, PMID 19735216.
AB. Pesaturo, HR. Jennings; SA. Voils, Terlipressin: vasopressin analog and novel drug for septic shock., in Ann Pharmacother, vol. 40, n. 12, Dec 2006, pp. 2170-7, DOI:10.1345/aph.1H373, PMID 17148649.
A. Delmas, M. Leone; S. Rousseau; J. Albanèse; C. Martin, Clinical review: Vasopressin and terlipressin in septic shock patients., in Crit Care, vol. 9, n. 2, Apr 2005, pp. 212-22, DOI:10.1186/cc2945, PMID 15774080.
LL. Gluud, K. Christensen; E. Christensen; A. Krag, Terlipressin for hepatorenal syndrome., in Cochrane Database Syst Rev, vol. 9, 2012, pp. CD005162, DOI:10.1002/14651858.CD005162.pub3, PMID 22972083.
SV. Sagi, S. Mittal; KS. Kasturi; GK. Sood, Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials., in J Gastroenterol Hepatol, vol. 25, n. 5, maggio 2010, pp. 880-5, DOI:10.1111/j.1440-1746.2009.06132.x, PMID 20074149.
F. Donnellan, G. Cullen; JE. Hegarty; PA. McCormick, Ischaemic complications of Glypressin in liver disease: a case series., in Br J Clin Pharmacol, vol. 64, n. 4, Oct 2007, pp. 550-2, DOI:10.1111/j.1365-2125.2007.02921.x, PMID 17880357.